Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages

Journal of Dermatological Science

Volumn 74, Issue 2, 2014, Pages 167-169

  Gehrke, Samuel ^a   Otsuka, Atsushi ^a   Huber, Roman ^a   Meier, Barbara ^a   Kistowska, Magdalena ^a   Fenini, Gabriele ^a   Cheng, Phil ^a   Dummer, Reinhard ^a   Kerl, Katrin ^a   Contassot, Emmanuel ^a   French, Lars E ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

IL 1 ; Inflammasome; Macrophage; Melanoma

Indexed keywords

ADAPTOR PROTEIN; ASC PROTEIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG; IL1B PROTEIN, HUMAN;

CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MACROPHAGE; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; NEVUS; PRIORITY JOURNAL; SKIN METASTASIS; SUPERFICIALLY SPREADING MELANOMA; IMMUNOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; INTERLEUKIN-1BETA; MACROPHAGES; MELANOMA;

EID: 84897111970     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.01.006     Document Type: Letter

References (10)

1. Gross O., Thomas C.J., Guarda G., Tschopp J. The inflammasome: an integrated view. Immunol Rev 2011, 243:136-151.
2. Arlt A., Vorndamm J., Muerkoster S., Yu H., Schmidt W.E., Folsch U.R., et al. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 2002, 62:910-916.
3. Elaraj D.M., Weinreich D.M., Varghese S., Puhlmann M., Hewitt S.M., Carroll N.M., et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res 2006, 12:1088-1096.
4. Bjorkdahl O., Wingren A.G., Hedhund G., Ohlsson L., Dohlsten M. Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo. Cancer Immunol Immunother 1997, 44:273-281.
5. Zipser M.C., Eichhoff O.M., Widmer D.S., Schlegel N.C., Schoenewolf N.L., Stuart D., et al. A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell Melanoma Res 2011, 24:326-333.
6. Hoek K.S., Schlegel N.C., Brafford P., Sucker A., Ugurel S., Kumar R., et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006, 19:290-302.
7. Yokoyama T., Sagara J., Guan X., Masumoto J., Takeoka M., Komiyama Y., et al. Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Cancer Lett 2003, 202:101-108.
8. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005, 37:853-862.
9. Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer 2000, 85:182-188.
10. Boni R., Boni R.A., Steinert H., Burg G., Buck A., Marincek B., et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose. Br J Dermatol 1995, 132:556-562.